Cargando…

Inflammatory Bowel Disease Reoperation Rate Has Decreased Over Time If Corrected by Prevalence

Despite the recent emergence of expensive biologic therapies, hospitalization and surgery remain important contributors for the overall costs of inflammatory bowel disease (IBD). In this study, we aimed to describe the burden of reoperations in patients with IBD by evaluating reoperation rates, char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santiago, Mafalda, Magro, Fernando, Correia, Luís, Portela, Francisco, Ministro, Paula, Lago, Paula, Trindade, Eunice, Dias, Cláudia Camila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494150/ https://www.ncbi.nlm.nih.gov/pubmed/33094955 http://dx.doi.org/10.14309/ctg.0000000000000227

Ejemplares similares

Rehospitalization rates, costs, and risk factors for inflammatory bowel disease: a 16-year nationwide study
por: Santiago, Mafalda, et al.
Publicado: (2020)

Incidence Trends of Inflammatory Bowel Disease in a Southern European Country: A Mirror of the Western World?
por: Santiago, Mafalda, et al.
Publicado: (2022)

What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale
por: Santiago, Mafalda, et al.
Publicado: (2019)

Age at Diagnosis Is Determinant for the Outcome of Inflammatory Bowel Disease: Is It a Myth?
por: Ministro, Paula, et al.
Publicado: (2021)

The risk of disabling, surgery and reoperation in Crohn’s disease – A decision tree-based approach to prognosis
por: Dias, Cláudia Camila, et al.
Publicado: (2017)

Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta‐analysis
por: Magro, Fernando, et al.
Publicado: (2021)

Composite outcomes in observational studies of Crohn’s disease: a systematic review and meta-analysis
por: Magro, Fernando, et al.
Publicado: (2022)

Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassays
por: Rocha, Cátia, et al.
Publicado: (2020)

Burden of Disease and Cost of Illness of Inflammatory Bowel Diseases in Portugal
por: Magro, Fernando, et al.
Publicado: (2022)

How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?—A prospective study
por: Magro, Fernando, et al.
Publicado: (2023)

A scoping review on early inflammatory bowel disease: definitions, pathogenesis, and impact on clinical outcomes
por: Estevinho, Maria Manuela, et al.
Publicado: (2022)

Thiopurines’ Metabolites and Drug Toxicity: A Meta-Analysis
por: Sousa, Paula, et al.
Publicado: (2020)

Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis
por: Magro, Fernando, et al.
Publicado: (2023)

RISK FACTORS FOR REOPERATION, MORBIDITY, AND MORTALITY IN PATIENTS WITH SMALL BOWEL OBSTRUCTION SUBMITTED TO SURGICAL TREATMENT
por: FIGUEROA-GIRALT, Manuel, et al.
Publicado: (2022)

Inflammatory bowel disease and thromboembolic events: a c’lot to learn
por: Carvalho, Ana Catarina, et al.
Publicado: (2022)

A survey on the impact of IBD in sexual health: Into intimacy
por: Pires, Francisco, et al.
Publicado: (2022)

Paper 32: Meniscus Repair Outcomes and Reoperation Rate in Patients Over the Age of 40
por: Berk, Alexander, et al.
Publicado: (2023)

Clinical performance of an infliximab rapid quantification assay
por: Magro, Fernando, et al.
Publicado: (2017)

Endoscopic duodenal stenting is efficient, but has higher rate of reoperations than gastrojejunostomy in palliative treatment for gastric outlet obstruction
por: Laitamäki, Matti, et al.
Publicado: (2022)

Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease
por: Pinto-Lopes, Pedro, et al.
Publicado: (2021)

Accuracy of the new rapid test for monitoring adalimumab levels
por: Rocha, Cátia, et al.
Publicado: (2019)

Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease
por: Costa Pereira, Cristiana, et al.
Publicado: (2017)

Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
por: Magro, Fernando, et al.
Publicado: (2017)

Reoperative Vascular Surgery
por: Rice, Henry
Publicado: (1988)

Reoperation following Pancreaticoduodenectomy
por: Reddy, J. R., et al.
Publicado: (2012)

Reoperation in Spinal Dysraphism
por: Mohanty, Aaron
Publicado: (2017)

Rhinoplasty Complications and Reoperations: Systematic Review
por: Crosara, Paulo Fernando Tormin Borges, et al.
Publicado: (2016)

Second-generation bi-cruciate stabilized total knee system has a lower reoperation and revision rate than its predecessor
por: Christen, Bernhard, et al.
Publicado: (2018)

Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays
por: Afonso, Joana, et al.
Publicado: (2016)

Viable Mycobacterium avium subsp. paratuberculosis Colonizes Peripheral Blood of Inflammatory Bowel Disease Patients
por: Estevinho, Maria Manuela, et al.
Publicado: (2023)

Open Tibial Fracture Treatment in Argentina: Reoperation Rates Following Surgical Management
por: Garabano, Germán, et al.
Publicado: (2022)

Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study
por: Buie, Michael J, et al.
Publicado: (2023)

Risk factors of emergency reoperations
por: Kim, Tae Kwan, et al.
Publicado: (2020)

Dienogest and the Risk of Reoperation in Endometriosis
por: Seo, Yong-Soo, et al.
Publicado: (2021)

Reoperation in Chiari-1 Malformations
por: Talamonti, Giuseppe, et al.
Publicado: (2023)

S. AUREUS IS ASSOCIATED WITH A GREATER NEED FOR REOPERATION IN SEPTIC ARTHRITIS OF THE KNEE
por: FERNANDES, LUCAS SAADE, et al.
Publicado: (2023)

Changing paradigms in management of inflammatory bowel disease
por: Mao, Ren, et al.
Publicado: (2022)

The Influence of Rheumatoid Arthritis on Higher Reoperation Rates over Time Following Lumbar Spinal Fusion—A Nationwide Cohort Study
por: Park, Jin-Sung, et al.
Publicado: (2022)

Does Laparoscopic Adhesiolysis Reduce the Risk of Small Bowel Obstruction Related Readmissions and Reoperations Compared to Open Adhesiolysis?
por: Park, Jin Hyung, et al.
Publicado: (2020)

A Meta-Analysis of Survival Outcomes Following Reoperation in Recurrent Glioblastoma: Time to Consider the Timing of Reoperation
por: Zhao, Yu-Hang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_90l9fa700em7h6otm0evo3p1g7